Mulmit

Enveric Biosciences, Inc.Enveric Biosciences, Inc.

ENVB Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2019-12-3139,914,675-2,296,534-2,410,673-2.83
2018-12-3142,998,280-7,146,460-16,897,516-20.47

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-06-01DeWitt Sheila18,518
2026-06-01Coveney Kevin MichaelChief Financial Officer133,333
2026-06-01Facchini Peter J.Chief Innovation Officer25,000
2026-06-01Tucker Joseph EdwardChief Executive Officer201,124
2026-06-01Kegler George A.18,518
2026-06-01Schabacker Marcus18,518
2026-06-01PASQUALONE FRANK18,518
2026-06-01WEBB MICHAEL D18,518
2025-12-23DeWitt Sheila7,633
2025-12-23Kegler George A.7,633
2025-12-23PASQUALONE FRANK7,633
2025-12-23Schabacker Marcus7,633

8-K events

FiledItems
2026-08-14Results of operations · Financial statements and exhibits
2026-06-09Other events · Financial statements and exhibits
2026-06-09Regulation FD disclosure · Financial statements and exhibits
2026-05-29Officer or director change · Submission of matters to a vote · Financial statements and exhibits
2026-05-15Results of operations · Financial statements and exhibits
2026-04-30Other events · Financial statements and exhibits
2026-04-20Entry into a material agreement · Unregistered sales of equity securities · Other events · Financial statements and exhibits
2026-03-27Results of operations · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.